FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895859833> ?p ?o ?g. }

• W2895859833 endingPage "196" @default.
• W2895859833 startingPage "196" @default.
• W2895859833 abstract "Hypoxia can induce chemoresistance, which is a significant clinical obstacle in cancer therapy. Here, we assessed development of hypoxia-induced chemoresistance (HICR) against free versus polymeric cisplatin micelles in a triple negative breast cancer cell line, MDA-MB-231. We then explored two strategies for the modulation of HICR against cisplatin micelles: a) the development of actively targeted micelles; and b) combination therapy with modulators of HICR in MDA-MB-231 cells. Actively targeted cisplatin micelles were prepared through surface modification of acetal-poly(ethylene oxide)-poly(α-carboxyl-ε-caprolactone) (acetal-PEO-PCCL) micelles with epidermal growth factor receptor (EGFR)-targeting peptide, GE11 (YHWYGYTPQNVI). Our results showed that hypoxia induced resistance against free and cisplatin micelles in MDA-MB-231 cells. A significant increase in micellar cisplatin uptake was observed in MDA-MB-231 cells that overexpress EGFR, following surface modification of micelles with GE11. This did not lead to increased cytotoxicity of micellar cisplatin, however. On the other hand, the addition of pharmacological inhibitors of key molecules involved in HICR in MDA-MB-231 cells, i.e., inhibitors of hypoxia inducing factor-1 (HIF-1) and signal transducer and activator of transcription 3 (STAT3), substantially enhanced the cytotoxicity of free and cisplatin micelles. The results indicated the potential benefit of combination therapy with HIF-1 and STAT3 inhibitors in overcoming HICR to free or micellar cisplatin." @default.
• W2895859833 created "2018-10-26" @default.
• W2895859833 creator A5006458744 @default.
• W2895859833 creator A5014900225 @default.
• W2895859833 creator A5017302401 @default.
• W2895859833 creator A5033028826 @default.
• W2895859833 creator A5047676248 @default.
• W2895859833 creator A5068442154 @default.
• W2895859833 creator A5073459160 @default.
• W2895859833 creator A5074337076 @default.
• W2895859833 date "2018-10-21" @default.
• W2895859833 modified "2023-09-25" @default.
• W2895859833 title "Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance" @default.
• W2895859833 cites W1497490920 @default.
• W2895859833 cites W1971347918 @default.
• W2895859833 cites W1971995358 @default.
• W2895859833 cites W1973345865 @default.
• W2895859833 cites W1983466982 @default.
• W2895859833 cites W1989659079 @default.
• W2895859833 cites W1990418094 @default.
• W2895859833 cites W1991551597 @default.
• W2895859833 cites W2011896471 @default.
• W2895859833 cites W2020935094 @default.
• W2895859833 cites W2023952192 @default.
• W2895859833 cites W2025182563 @default.
• W2895859833 cites W2032134888 @default.
• W2895859833 cites W2035291856 @default.
• W2895859833 cites W2037877043 @default.
• W2895859833 cites W2039059397 @default.
• W2895859833 cites W2040427619 @default.
• W2895859833 cites W2052478197 @default.
• W2895859833 cites W2062843221 @default.
• W2895859833 cites W2066457548 @default.
• W2895859833 cites W2068148025 @default.
• W2895859833 cites W2081477031 @default.
• W2895859833 cites W2082511916 @default.
• W2895859833 cites W2086632595 @default.
• W2895859833 cites W2087327936 @default.
• W2895859833 cites W2088715496 @default.
• W2895859833 cites W2091068407 @default.
• W2895859833 cites W2093469424 @default.
• W2895859833 cites W2096027508 @default.
• W2895859833 cites W2097950450 @default.
• W2895859833 cites W2103293124 @default.
• W2895859833 cites W2110233014 @default.
• W2895859833 cites W2114333854 @default.
• W2895859833 cites W2115439624 @default.
• W2895859833 cites W2116966799 @default.
• W2895859833 cites W2117525838 @default.
• W2895859833 cites W2131430454 @default.
• W2895859833 cites W2135117965 @default.
• W2895859833 cites W2136374331 @default.
• W2895859833 cites W2146607395 @default.
• W2895859833 cites W2147671525 @default.
• W2895859833 cites W2153957030 @default.
• W2895859833 cites W2156871941 @default.
• W2895859833 cites W2164254541 @default.
• W2895859833 cites W2165836181 @default.
• W2895859833 cites W2165869937 @default.
• W2895859833 cites W2320866708 @default.
• W2895859833 cites W2349760070 @default.
• W2895859833 cites W2401893904 @default.
• W2895859833 cites W2408212242 @default.
• W2895859833 cites W2551299239 @default.
• W2895859833 cites W2763023265 @default.
• W2895859833 cites W2892469985 @default.
• W2895859833 cites W2982470286 @default.
• W2895859833 cites W49854963 @default.
• W2895859833 doi "https://doi.org/10.3390/pharmaceutics10040196" @default.
• W2895859833 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6320993" @default.
• W2895859833 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30347860" @default.
• W2895859833 hasPublicationYear "2018" @default.
• W2895859833 type Work @default.
• W2895859833 sameAs 2895859833 @default.
• W2895859833 citedByCount "16" @default.
• W2895859833 countsByYear W28958598332019 @default.
• W2895859833 countsByYear W28958598332020 @default.
• W2895859833 countsByYear W28958598332021 @default.
• W2895859833 countsByYear W28958598332022 @default.
• W2895859833 countsByYear W28958598332023 @default.
• W2895859833 crossrefType "journal-article" @default.
• W2895859833 hasAuthorship W2895859833A5006458744 @default.
• W2895859833 hasAuthorship W2895859833A5014900225 @default.
• W2895859833 hasAuthorship W2895859833A5017302401 @default.
• W2895859833 hasAuthorship W2895859833A5033028826 @default.
• W2895859833 hasAuthorship W2895859833A5047676248 @default.
• W2895859833 hasAuthorship W2895859833A5068442154 @default.
• W2895859833 hasAuthorship W2895859833A5073459160 @default.
• W2895859833 hasAuthorship W2895859833A5074337076 @default.
• W2895859833 hasBestOaLocation W28958598331 @default.
• W2895859833 hasConcept C109316439 @default.
• W2895859833 hasConcept C11268172 @default.
• W2895859833 hasConcept C12554922 @default.
• W2895859833 hasConcept C126322002 @default.
• W2895859833 hasConcept C178790620 @default.
• W2895859833 hasConcept C184651966 @default.
• W2895859833 hasConcept C185592680 @default.
• W2895859833 hasConcept C202751555 @default.

• next